Europe’s distinct biotech venture studio model

EUROPEAN BIOTECHNOLOGY MAGAZINE - For decades, biotech companies were formed around a discovery: a promising biological signal, a novel target, a platform emerging from academic research. Now a different formation model is gaining momentum: venture studios. These entities don't just fund startups, they assemble them, testing hypotheses, building teams and infrastructure, and only then spinning out companies designed to scale. Read more

www.istockphoto.com/Yuri